Last updated on January 2019
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
Brief description of study
The purpose of this study is to evaluate the efficacy of pimavanserin by comparing pimavanserin with placebo in preventing a relapse of psychotic symptoms in subjects with dementia-related psychosis and who were stabilized after 12 weeks of open label pimavanserin treatment.
Clinical Study Identifier: NCT03325556
Start Over
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »
Connect »